References
Drees M, Pineles L, Harris AD, Morgan DJ (2014) Variation in definitions and isolation procedures for multidrug-resistant Gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network. Infect Control Hosp Epidemiol 35(4):362–366. doi:10.1086/675600
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al (2011) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281. doi:10.1111/j.1469-0691.2011.03570.x
Struve C, Roe CC, Stegger M et al; mBio (2015) Mapping the evolution of hypervirulent K. pneumoniae. Am Soc Microbiol6(4):1–12. doi:10.1128/mBio.00630-15
Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11(4):589–603
Falcone M, Russo A, Iacovelli A, Restuccia G, Ceccarelli G, Giordano A, Farcomeni A, Morelli A, Venditti M (2016) Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect 22(5):444–450. doi:10.1016/j.cmi.2016.01.016
Seibert G, Horner R, Meneghetti BH et al (2014) Nosocomial infections by K. pneumoniae carbapenemase producing enterobacteria in a teaching hospital. Einstein (Sao Paulo) 12(3):281–286. doi:10.1590/S1679-45082014AO3131
Satlin MJ, Jenkins SG, Walsh TJ (2014) The global challenge of carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis 9(12):1–12. doi:10.1093/cid/ciu052
Lin JN, Chen YH, Chang LL, Lai CH, Lin HL, Lin HH (2011) Clinical characteristics and outcomes of patients with extended-spectrum β-lactamase-producing bacteremias in the emergency department. Intern Emerg Med 6(6):547–555. doi:10.1007/s11739-011-0707-3
European Surveillance of Antimicrobial Consumption Network (2014) Antimicrobial resistance interactive database. http://ecdc.europa.eu/en/chealthtopics/antimicrobial_resistance/esac-net-database. Accessed 10 Nov 2016
L’utilizzo di antibiotici e l’antibiotico-resistenza in Toscana (2015) Secondo report della Rete di Sorveglianza dell’Antibiotico Resistenza in Toscana (SART). https://www.ars.toscana.it/files/pubblicazioni/Volumi/2016/Documento_ARS_91_2017_18_gennaio_rev2.pdf. Accessed 15 Feb 2017
Giamarellou H, Galani L, Baziaka F, Karaiskos I (2013) Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant K. pneumoniae. Antimicrob Agents Chemother 57(5):2388–2390. doi:10.1128/AAC.02399-12
Falcone M, Paterson D Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections. J Antimicrob Chemother 71(10):2713–2722. doi:10.1093/jac/dkw239
Humphries RM, Yang S, Hemarajata P, Ward KW, Hindler JA, Miller SA, Gregson A (2015) First report of ceftazidime–avibactam resistance in a KPC-3-expressing Klebsiella pneumoniae isolate. Antimicrob Agents Chemother 59(10):6605–6607. doi:10.1128/AAC.01165-15
Choi MJ, Kim S, Ko KS (2016) Pathways regulating the pbgP operon and colistin resistance in Klebsiella pneumoniae strains. J Microbiol Biotechnol 26(9):1620–1628. doi:10.4014/jmb.1604.04016
Tascini C, Tagliaferri E, Giani T, Leonildi A, Flammini S, Casini B, Lewis R, Ferranti S, Rossolini GM, Menichetti F (2013) Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 57(8):3990–3993. doi:10.1128/AAC.00179-13
Yin Y, Yue Z, Zhang Y, Li F, Zhang Q (2016) Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae. Rev Soc Bras Med Trop 49(2):165–171. doi:10.1590/0037-8682-0411-2015
Bulik CC, Nicolau DP (2011) Double-carbapenem therapy for carbapenemase-producing K. pneumoniae. Antimicrob Agents Chemother 55(6):3002–3004. doi:10.1128/AAC.01420-10
Morrill HJ, Pogue JM, Kaye KS, LaPlante KL (2015) Treatment options for carbapenem-resistant enterobacteriaceae infections. Open Forum Infect Dis. doi:10.1093/ofid/ofv050
Ceccarelli G, Falcone M, Giordano A, Mezzatesta ML, Caio C, Stefani S, Venditti M (2013) Successful ertapenem–doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing K. pneumoniae. Antimicrob Agents Chemother 57(6):2900–2901. doi:10.1128/AAC.00188-13
Oliva A, D’Abramo A, D’Agostino C, Iannetta M, Mascellino MT, Gallinelli C, Mastroianni CM, Vullo V (2014) Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections. J Antimicrob Chemother 69(6):1718–1720. doi:10.1093/jac/dku027
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Statement of human and animal rights
The clinical case was managed in accordance to human rights as stated by the updated version of Helsinky declaration.
Informed consent
Written informed consent was obtained by the patient.
Rights and permissions
About this article
Cite this article
Pieralli, F., Baroncelli, S., Farese, A. et al. Every cloud has a silver lining. Intern Emerg Med 12, 811–815 (2017). https://doi.org/10.1007/s11739-017-1675-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-017-1675-z